Scorpion Capital

Scorpion Capital, on Friday, disclosed a short seller report on TransMedics Group Inc (NASDAQ:TMDX), accusing the organ transplant technology company of fraudulent practices, including kickbacks, billing fraud and unreported device failures. Scorpion alleges that TransMedics engages in “...

Shares of synthetic biology company Ginkgo Bioworks Holdings Inc (NYSE: DNA) traded lower by more than 20% on Wednesday. What Happened? In a new report, Citron Research editor Andrew Left said called Ginkgo "a scheme” and said the company’s recent $24 billion valuation is...